CLL

ASH: Eli Lilly plots 'ambitious' cancer program after sharing early BTK data
Fierce Biotech
Sun, 12/8/19 - 10:20 pm
Eli Lilly
Loxo Oncology
ASH2019
CLL
ASH19: AZ’s Calquence throws gauntlet down to Imbruvica
Pharmaforum
Sun, 12/8/19 - 10:17 pm
AstraZeneca
cancer
Calquence
ASH2019
Imbruvica
JNJ
AbbVie
CLL
ASH: AbbVie, Roche pad their case for fixed-duration Venclexta use in CLL
Fierce Pharma
Sun, 12/8/19 - 10:12 pm
AbbVie
Roche
CLL
ASH2019
Venclexta
AstraZeneca's Calquence Wins FDA Approval for Chronic Lymphocytic Leukemia
BioSpace
Mon, 11/25/19 - 09:46 am
AstraZeneca
FDA
CLL
SLL
Calquence
AstraZeneca's Calquence steps up to challenge Imbruvica with big CLL green light
Fierce Pharma
Thu, 11/21/19 - 06:26 pm
AstraZeneca
Calquence
Imbruvica
CLL
JNJ
AbbVie
AbbVie submits sNDA to FDA for IMBRUVICA, Rituximab combo for CLL
Pharmaceutical Business Review
Mon, 11/11/19 - 10:58 am
AbbVie
Imbruvica
rituximab
CLL
SLL
AstraZeneca Has Dazzled in Recent Cancer Trials, but Faces Stiff Competition
BioSpace
Thu, 06/27/19 - 06:38 pm
AstraZeneca
clinical trials
Imfinzi
extensive-stage small cell lung cancer
Calquence
CLL
AstraZeneca's Calquence sets Imbruvica in its sights with big CLL survival numbers
Fierce Pharma
Mon, 06/17/19 - 11:21 pm
AstraZeneca
Calquence
CLL
Imbruvica
AstraZeneca ends another Calquence trial early
Pharmaforum
Thu, 06/6/19 - 09:55 am
AstraZeneca
CLL
Calquence
clinical trials
AbbVie, Roche snag another CLL nod, this time for Venclexta-Gazyva
Fierce Pharma
Thu, 05/16/19 - 10:53 am
AbbVie
Roche
Venclexta
CLL
small lymphocytic leukemia
ASH successes set to lift Imbruvica in CLL
Biopharma Dive
Thu, 12/6/18 - 07:01 pm
AbbVie
Imbruvica
CLL
JNJ
ASH 2018
ASH18: CAR-T shows up in early CLL test
Biopharma Dive
Sun, 12/2/18 - 10:48 pm
Celgene
CAR-T
CLL
ASH2018
JCAR017
Roche and AbbVie Push Towards First-Line CLL Treatment
BioSpace
Thu, 11/1/18 - 11:28 am
Roche
Genentech
AbbVie
clinical trials
Venclexta
Gazyva
CLL
chronic lymphocytic leukemia
AbbVie’s CLL drug Venclyxto too expensive for NHS, says NICE
Pharmaforum
Fri, 10/26/18 - 09:54 am
NICE
AbbVie
Venclyxto
Roche
Rituxan/MabThera
CLL
Priority Review for Imbruvica-Gazyva combo to treat CLL, SLL
BioCentury
Wed, 10/17/18 - 12:24 pm
AbbVie
FDA
priority review
Imbruvica
Gazyva
CLL
SLL
TG stock sinks after setback to blood cancer trial
Fierce Biotech
Tue, 09/25/18 - 09:59 am
TG Therapeutics
FDA
ublituximab-umbralisib
CLL
chronic lymphocytic leukemia
Eagle Pharmaceuticals Receives New Patent for Bendeka Configure
CP Wire
Tue, 07/3/18 - 10:15 am
Eagle Pharmaceuticals
Bendeka
Teva Pharmaceuticals
CLL
patents
AbbVie, Roche post a big win with a blockbuster FDA OK for Venclexta/Rituxan combo for leukemia
Endpoints
Mon, 06/11/18 - 09:17 am
AbbVie
Roche
Venclexta
Rituxan
CLL
chronic lymphocytic leukemia
AbbVie eyes Imbruvica expansion in CLL as Gazyva pairing hits its marks
Fierce Pharma
Thu, 05/24/18 - 05:44 pm
AbbVie
Imbruvica
CLL
Gazyva
At Verastem, Infinity’s Former Blood Cancer Drug Heads to FDA
Xconomy
Fri, 02/9/18 - 09:34 am
Verastem
Infinity Pharma
FDA
duvelisib
CLL
follicular lymphoma
small lymphocytic lymphoma

Pages